Cell Biosciences Signs Agreement to Acquire Alpha Innotech Corp. (APNO.OB) for $17.6 Million
Cell Biosciences, Inc., a private life sciences company focused on nanoproteomics, and Alpha Innotech Corp., a leading developer, manufacturer and marketer of digital imaging and analysis systems, recently announced that Cell Biosciences will acquire Alpha Innotech for $1.50 per share or approximately $17.9 million in cash. In 2008, Alpha Innotech achieved revenues of $17.6 million and was profitable on both an operating and a net income basis. The completion of the transaction is subject to customary terms and conditions, including approval by the Alpha Innotech stockholders. The directors, executive officers and certain stockholders of Alpha Innotech, who collectively hold approximately…